Page 108 - วารสารกรมการแพทย์แผนไทยฯ ปีที่ 11 ฉบับที่ 2
P. 108

202  «“√ “√°“√·æ∑¬å·ºπ‰∑¬·≈–°“√·æ∑¬å∑“߇≈◊Õ°          ªï∑’Ë 11 ©∫—∫∑’Ë 2 情¿“§¡- ‘ßÀ“§¡ 2556




             ·æ∑¬å ®–√à«¡°—πæ‘®“√≥“«à“®– “¡“√∂√—°…“¥â«¬  VIMEDIMEX MEDI-PHARMA JOINT-STOCK

             ·ºπªí®®ÿ∫—πÀ√◊Õ àßμàÕ √æ.√–¥—∫Õ”‡¿Õ ®—ßÀ«—¥  COMPANY ·≈–THIEN THAO PHARMACEU-
                 7.4 ∫∑∫“∑Àπâ“∑’Ë¢Õß·æ∑¬å·ºπ¥—È߇¥‘¡„π‚√ß  TICAL LIMITED COMPANY ¥—ßπ—Èπ™◊ËÕ√«¡§◊Õ BV
             欓∫“≈√–¥—∫μ”∫≈                            Pharma Joint-Stock Company °àÕμ—È߇ªìπ

                    - μ√«®√—°…“ TM                      ∑“ß°“√™◊ËÕπ’È ‡¡◊ËÕ 19 °—𬓬π 2008 ∫√‘…—∑¡’‡§√◊Õ
                    -  à߇ √‘¡„Àâª√–™“™π π„®¡“„™â TM    ¢à“¬«—μ∂ÿ¥‘∫∑’Ë Tan Thanh Tay Village, Cu Chi
                    - ®—¥√“¬°“√∑“ß ∂“π’«‘∑¬ÿ„Àâª√–™“™π  Dist., ‡¡◊Õß‚Œ®‘¡‘πÀå  ”π—°ß“πÕ¬Ÿà 2 ·Ààß§◊Õ‚Œ®‘¡‘πÀå

              π„®¡“„™â TM ‡¥◊Õπ≈– 4 §√—Èß               ·≈–Œ“πÕ¬
                    - ª√–™ÿ¡„πμ”∫≈ ‚¥¬π”§«“¡√Ÿâ‡°’ˬ«°—∫     °“√º≈‘μ ®–º≈‘쬓·ºπªí®®ÿ∫—π·≈–¬“·ºπ

             TM ‰ªæŸ¥§ÿ¬¥â«¬                            ‚∫√“≥·≈–Õ“À“√‡ √‘¡ ∑ÿ°√Ÿª·∫∫‰¥â·°à ¬“‡¡Á¥
                    - ·®°„∫ª≈‘«„Àâª√–™“™π¡“μ√«®√—°…“    (·∫∫‰¡à‡§≈◊Õ∫ ‡§≈◊Õ∫øî≈¡å ‡§≈◊Õ∫πÈ”μ“≈) ·§ª´Ÿ≈
             ¥â«¬ TM                                    ‡¡Á¥øŸ (effervescent tablets) ¬“πÈ” ¬“¿“¬πÕ° ‡™àπ

                    - ª√–™“ —¡æ—π∏å°“√√—°…“¥â«¬ TM °—∫  §√’¡ ‡®≈ πÕ°®“°π’Ȭ—߇ªìπμ—«·∑π®”Àπà“¬ “√ °—¥
             ºŸâªÉ«¬∑’Ë¡“√—∫∫√‘°“√                       ¡ÿπ‰æ√∑’ËμâÕß„™â‡∑§π‘§∑”·Àâߥ⫬ spray dry

                    - ®—¥ «π ¡ÿπ‰æ√ ‡ªìπ «πμ—«Õ¬à“ß ´÷Ëß¡’  (´÷Ëß‚√ßß“π·Ààßπ’ȇªìπ·Ààß·√°„π‡«’¬μπ“¡∑’Ë¡’°“√
             3 √Ÿª·∫∫ (‡ªìππ‚¬∫“¬¢Õß°√–∑√«ß “∏“√≥ ÿ¢)   º≈‘μ “√ °—¥¥â«¬«‘∏’°“√π’È·≈–∑”‡ªìπÕÿμ “À°√√¡
             ‰¥â·°à 1) º—°∑’ˇªìπ ¡ÿπ‰æ√ 2) º≈‰¡â∑’ˇªìπ ¡ÿπ‰æ√   àßÕÕ°) ·≈–¬—ß¡’ Freeze dry √–¥—∫Õÿμ “À°√√¡

             ·≈– 3) μâπ‰¡âª√–¥—∫‡ªìπ ¡ÿπ‰æ√             ∑’Ë„™âº≈‘μ “√ °—¥°√–‡∑’¬¡ °“√º≈‘μ “√ °—¥
                    - „Àâ§”·π–π” à߇ √‘¡„Àâª√–™“™πª≈Ÿ°  ®“°æ◊™¡“°°«à“ 20 ™π‘¥∑’ˉ¥â¢“¬¢≥–π’È ®π∑”„Àâ
              ¡ÿπ‰æ√„π§√—«‡√◊Õπ Õ¬à“ßπâÕ¬§√—«‡√◊Õπ≈– 5 - 10  ∫√‘…—∑π’ȉ¥â√—∫√“ß«—≈„π°“√¡’ à«π√à«¡„π°“√º≈‘μ

             ™π‘¥                                       º≈‘μ¿—≥±å∑’Ë¡’§ÿ≥§à“∑“ßæ◊Èπ∫â“π ·Ààß™“μ‘
                    - ÕÕ°¥Ÿ·≈ºŸâªÉ«¬‡√◊ÈÕ√—ß„π™ÿ¡™π ‡¥◊Õπ≈– 1  ‚√ßß“πº≈‘μ¢Õß BV pharma  √â“ßμ“¡
             - 2 §√—Èß                                  ¡“μ√∞“π GMP ¢Õß WHO guild line ‚√ßß“π

                                                        ‡√‘Ë¡°àÕ √â“ß 1 °√°Æ“§¡ 2003 ‡ √Á®‡¥◊Õπæƒ»®‘°“¬π
             8. °“√»÷°…“¥Ÿß“π∑’Ë ‚√ßß“π BV Pharma
                                                        2004 ¡’æ◊Èπ∑’˺≈‘μ 19,550 μ“√“߇¡μ√ ·∫àßæ◊Èπ∑’Ë¥—ßπ’È
                Joint-Stock Company
                                                              ”π—°ß“π (414 μ“√“߇¡μ√) º≈‘μ “√ °—¥
                 ™◊ËÕ BV- pharma ¡“®“°§”«à“ British Viet-  (2000 μ“√“߇¡μ√) º≈‘쬓 2  “¬°“√º≈‘μ (1,440
             nam Pharma ‡ªìπ∫√‘…—∑∑’˺≈‘μ ∑—È߬“·ºπªí®®ÿ∫—π  μ“√“߇¡μ√) º≈‘μÕ“À“√‡ √‘¡ (520 μ“√“߇¡μ√)

             ·≈–¬“®“° ¡ÿπ‰æ√ ‡ªìπ∫√‘…—∑∑’ˉ¥â√—∫∂à“¬∑Õ¥  °“√§«∫§ÿ¡§ÿ≥¿“æ (370 μ“√“߇¡μ√) ∑’ˇ°Á∫
             ‡∑§π‘§∑“ß°“√§â“·≈–‡∑§‚π‚≈¬’®“° British Virgin  º≈‘μ¿—≥±å (988 μ“√“߇¡μ√) æ◊Èπ∑’Ë∑’Ë„™â support

             Islands ¥—ßπ—Èπ™◊ËÕ∫√‘…—∑®÷ß¡’§”«à“ British ¥â«¬  ‚√ßß“π·≈–√–∫∫ (1,800 μ“√“߇¡μ√)
             ·≈–¬—ß¡’ 2 ∫√‘…—∑„π‡«’¬¥π“¡‡¢â“√à«¡§◊Õ          ∫ÿ§≈“°√„π à«π¢Õß√–∫∫ √«¡∑—Èß ‘Èπ 322 §π
   103   104   105   106   107   108   109   110   111   112   113